This article available in Chinese version only

港股成交昨創新高 續看好可留意港交牛51399/恒指購22369

2021-01-20 11:17:47

大市昨日迎來數宗好消息,恒指不但創逾一年半新高,整體市場成交亦超過三千億元,創歷來最高。北水昨日淨流入逾261億元人民幣,同是有紀錄以來新高,其中港交所(0388)為淨買入第二多,金額超過33億元。在成交增加及市場憧憬陸續有內地企業來港上市的支持下,港交所股價連番創新高昨見525元,即市升幅減半後今天再發力。投資者若續看好港交所股價,可留意牛證51399, 收回價 451.88 元, 2021年10月到期 ,實際槓桿 7.4 倍; 相反如看淡則可留意熊證63139, 收回價 542.88 元, 2021年12月到期 ,實際槓桿 14.1 倍。


恒指周一及周二累升逾1,068點後今天再接再厲,逼近三萬點大關。上日恒指淡倉有超過2.5億元資金淨流入,好倉牛證雖淨流出7,700萬元,但同時認購證淨吸約3,588萬元。恒指升,相關恒指波幅指數亦上升,投資者若續看好恒指及相關波動性,可留意認購證22369,行使價 31000 點, 2021年12月到期 ,實際槓桿 6.9 倍; 相反如看淡恒指可留意熊證67130, 收回價 30488 點, 2021年12月到期 ,實際槓桿 29.7 倍。




港交認購證29793,行使價 568.88 元, 2021年7月到期 ,實際槓桿 5.7 倍。

港交認沽證29409,行使價 398.88 元, 2021年7月到期 ,實際槓桿 6.7 倍。

港交牛證51399,行使價 449.38 元, 收回價 451.88 元, 2021年10月到期 ,實際槓桿 7.4 倍。

港交熊證63139,行使價 545.38 元, 收回價 542.88 元, 2021年12月到期 ,實際槓桿 14.1 倍。


恒指認購證22369,行使價 31000 點, 2021年12月到期 ,實際槓桿 6.9 倍。

恒指認沽證29392,行使價 26888 點, 2021年12月到期 ,實際槓桿 5.9 倍。

恒指牛證51476,行使價 28473 點, 收回價 28573 點, 2023年8月到期 ,實際槓桿 24.7 倍。

恒指熊證67130,行使價 30588 點, 收回價 30488 點, 2021年12月到期 ,實際槓桿 29.7 倍。


更新日期及時間: 2021年1月20日  上午10:15

Intrady newsletters
Back to Intrady newsletters



Sign up to our newsletter

Stay abreast of the trends with the latest investment insight and market updates.

Latest article

(Available in Chinese only)
Back to Intrady newsletters

Important Risk Warning

The structured products are not collateralized. If the issuer is insolvent or defaults, investors may not recover part or all of the amount due.

Structured products are complex products. Investors should exercise caution in relation to them. The price of the structured products may fall in value as rapidly as it may rise and investors may sustain a total or substantial loss of their investment. Prospective investors should ensure that they understand the nature and risks and seek professional advice where applicable. Please also note that CBBCs have a mandatory call feature and may therefore be subject to early termination, upon which (i) investors in category N CBBCs will lose all of their investments in the CBBCs; and (ii) the residual value of category R CBBCs may be zero. Inline warrants have been newly introduced to the market and there are no similar products currently listed on the Stock Exchange of Hong Kong Limited for comparison. Inline warrants carry exotic features, and their terms and pricing may be more complicated than standard derivative warrants. Maximum potential payoff is fixed and capped. Price movement of the inline warrants may be disproportionate or opposite to the price movement of the underlying asset. Trading structured products with United States (US) underlying index may be exposed to additional risks, including (a) risks relating to difference in trading days and hours, (b) less public information about the index and such information may not be available in Chinese, (c) political and economic risks relating to the index regions (such as the US), (d) exchange rate risks, (e) possible delay in settlement, and (f) publication of index level when component shares are not trading. Click here for "Terms of Use".


By viewing this website or using any information or functions of this website, you are deemed to acknowledge that you agree to the Privacy and Security, Terms of Use and Hyperlink Policy. Click here for "Disclaimer".

All data/charts are for reference purposes only.